Abstract:1862 Objectives: To prepare 99mTc-IT-rituximab, a novel sentinel lymphoscintigraphy agent, and evaluate its ability in detecting the sentinel lymph node. Methods: Rituximab was radiolabeled with 99mTc via 2-iminothiolane (2-IT). The resulting 99mTc-IT-Rituximab were analysed for number of free sulfhydryl groups. The integrity of IT-rituximab was evaluated by SDS-PAGE, ELISA, which could evaluated the optimal modifying conditions. The immunological biology of 99mTc-IT-rituximab was evaluated by flow-cytometric analysis (FCA). Comparing the radiocolloid, 99mTc-IT-Rituximab was evaluated with biological distribution results, and image of sentinel lymph node (SLN) was obtained at 30min-24h postinjection with 99mTc-IT-rituximab in mice. The influenced factors on the imaging by the injecting dosage and volume were also observed in mice. Results: Optimal conditions for modifying Rituximab involved a 10:1 molar ratio of 2-IT : protein in 4°C, the number of apparent thiol produced were 2.1 per IT-Rituximab. 99mTc-IT-rituximabwas stable for 24 h at 37°C in human serum. 99mTc-IT-rituximab was proved to have the similar immunological character with rituximab by SDS-PAGE, ELISA and FCA. Its binding rate of B lymphoma cell line Raji cell is 69.4%. After subcutaneous injection into the foot pads of mice, 99mTc-IT-rituximab showed high accumulationn the knee. The mean %ID of the popliteal lymph node at 1, 4, 8, and 24 h was (2.33±0.13)%, (2.72±0.12)%, (3.71±0.28)%, and (4.49±0.43)%, respectively. The mean %ID of NSLN was less than 0.2% at each time point. With increasing the injected dose or volume the %ID of SLN would decrease, while the %ID of NSLN would increase gradually. 99mTc-IT-rituximab exhibited faster injection site clearance than did 99mTc-SC and 99mTc-DX, %ID of the rear paws was (22.14±2.08)% at 24 h after administration. In mice, the results of dynamic SLN mapping show that SLN could be seen within a wide range from 30 min to 24 h postinjection. The higher order nodes had not been seen all the time. 99mTc-IT-rituximab was mainly excreted by kidney, other tissues exhibited less than 1 percent of the injected dose at all time points. For radiocolloid, the higher echelon node extraction was significantly higher. The 99mTc-SC and 99mTc-DX %ID of the second-order node was (4.93±0.37) % and (8.54±0.78) % at 2 h. The uptake of second echelon for 99mTc-HSA was also higher than 99mTc-IT-rituximab. Conclusions: 99mTc-IT-Rituximab, as a tracer to mapping SLN, could predict the status of SLNs reliably.

Development of Lymphatic Nodes in the Chinese Reference Adult Male Voxel Model (CRAM) with Applications to Radionuclide Therapy

Use of Diffusion-Weighted Magnetic Resonance Imaging in Cervical Lymph Node Metastasis from Nasopharyngeal Carcinoma Patients Receiving Intensity Modulated Radiation Therapy

A Radiomic Approach to Access Tumor Immune Status by CD8<SUP>+</SUP>TRMs on Surgically Resected Non-Small-Cell Lung Cancer

Development of the Lymphatic System in the 4D XCAT Phantom

Chinese Reference Digital Voxel Phantoms for Radiation Protection Systems

Establishment of the Detailed Breast Model of Chinese Adult Female and Application in External Radiation Protection

Monte Carlo Simulation for Internal Radiation Dosimetry Based on the High Resolution Visible Chinese Human

Development and validation of a radiomics model based on lymph-node regression grading after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

The Study on the Potential Clinical Value of Sentinel Lymphoscintigraphy in the Radiation Target Volume Design of Internal Mammary Nodes

A Multi-Center Study of CT-Based Neck Nodal Radiomics for Predicting an Adaptive Radiotherapy Trigger of Ill-Fitted Thermoplastic Masks in Patients with Nasopharyngeal Carcinoma

An ICRP-based Chinese adult male voxel model and its absorbed dose for idealized photon exposures—the skeleton

Distribution of involved regional lymph nodes in recurrent and locally advanced breast cancer and its impact on target definition

Development of Chinese mesh-type pediatric reference phantom series and application in dose assessment of Chinese undergoing computed tomography scanning

LymphoDose: a lymphocyte dose estimation framework - application to brain radiotherapy

Individualized Clinical Target Volume for Irradiation of the Supraclavicular Region in Breast Cancer Based on Mapping of the Involved Ipsilateral Supraclavicular Lymph Nodes

Development of a PET/CT molecular radiomics-clinical model to predict thoracic lymph node metastasis of invasive lung adenocarcinoma ≤ 3 cm in diameter

Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer

Implication of ICRP pediatric reference voxel phantoms on dose assessment of patients in radioiodine therapy

Development and animal study of sentinel lymph node imaging with a novel radiotracer

Organ dose conversion coefficients on an ICRP-based Chinese adult male voxel model from idealized external photons exposures

Locally advanced rectal cancer:an MRI radiomics study on lymph node re-evaluation after neoadjuvant chemoradiotherapy